San Francisco, United States
IRIS invests in multiple asset classes, focusing predominantly on technology and life sciences. The group employs a quantitative investment strategy, has a preference for North American opportunities, and is flexible in terms of investment stage and sector within its areas of focus.
55
Total Investments
29
Portfolio Companies
-
Exits
-
Industries
General Information
Company Overview
About IRIS
Recent Investments (55)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series Unknown | •••••• | Sep 2026 | |
| Series A | •••••• | Mar 2026 | |
| Series A | •••••• | Sep 2025 | |
| Series B | •••••• | Apr 2025 | |
| Seed | •••••• | Jun 2023 | |
•••• ••••
|
Series A | •••••• | Jun 2022 |
|
•••• ••••
|
Series A | •••••• | Sep 2021 |
|
•••• ••••
|
Series D | •••••• | May 2021 |
|
•••• ••••
|
Late Vc | •••••• | Jan 2021 |
|
•••• ••••
|
Series C | •••••• | Jan 2021 |
Latest News
French cardiac monitoring startup Implicity reports 26% lower mortality as it raises €35 million
Eu-startups · Sep 09, 2026
OpsMill raises $14m Series A to make IT infrastructure data trustworthy enough for AI agents
Thenextweb · May 07, 2026
OpsMill raises $14M to address enterprise infrastructure data challenges
Tech · May 07, 2026
France’s OpsMill raises €11.9 million to help enterprises prepare infrastructure data for AI and automation
Eu-startups · May 07, 2026
What Happened on the Second Day of the Tech.eu Summit London 2026?
Apr 22, 2026
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
